| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Sorafenib | GDSC1000 | pan-cancer | AAC | -0.038 | 0.5 |
| mRNA | PLX4720 | CCLE | pan-cancer | AAC | -0.032 | 0.5 |
| mRNA | BRD-A86708339 | CTRPv2 | pan-cancer | AAC | 0.04 | 0.5 |
| mRNA | JQ-1:MK-0752 (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.026 | 0.5 |
| mRNA | BRD-K66453893 | CTRPv2 | pan-cancer | AAC | -0.024 | 0.5 |
| mRNA | IOX2 | GDSC1000 | pan-cancer | AAC | -0.024 | 0.5 |
| mRNA | AC55649 | CTRPv2 | pan-cancer | AAC | 0.029 | 0.5 |
| mRNA | AZD4547 | CTRPv2 | pan-cancer | AAC | 0.029 | 0.5 |
| mRNA | ciclosporin | CTRPv2 | pan-cancer | AAC | -0.029 | 0.5 |
| mRNA | BRD-K80183349 | CTRPv2 | pan-cancer | AAC | 0.025 | 0.5 |